Matches in Nanopublications for { ?s ?p "[CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 24 of
24
with 100 items per page.
- NP451876.RAssKPnTSj2K0chrOIabCINJuwJYtM0pjX7t6c_DkLXok130_assertion description "[CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP451876.RAssKPnTSj2K0chrOIabCINJuwJYtM0pjX7t6c_DkLXok130_provenance.
- NP628827.RAvbi3-vi38pF3Aq7byWhJd2cGMTb5jqF24wP_yoqG-fg130_assertion description "[CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP628827.RAvbi3-vi38pF3Aq7byWhJd2cGMTb5jqF24wP_yoqG-fg130_provenance.
- assertion description "[CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP256607.RAa-0fcmURpWMh3kFecg2b-hhrpi2ESK_Rdy8SFpegrkU130_assertion description "[CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP256607.RAa-0fcmURpWMh3kFecg2b-hhrpi2ESK_Rdy8SFpegrkU130_provenance.
- assertion description "[CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP634492.RAewKvKpFCE6bMIovXHcnx7hxax5yi-_zTh2-H45bbmv8130_assertion description "[CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP634492.RAewKvKpFCE6bMIovXHcnx7hxax5yi-_zTh2-H45bbmv8130_provenance.
- NP634494.RAS8KURIs6nGxm530wiVV1QpHL0JktrmYdErZnUVsMo34130_assertion description "[CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP634494.RAS8KURIs6nGxm530wiVV1QpHL0JktrmYdErZnUVsMo34130_provenance.
- NP634495.RAYurdp1yGzZXNnD3aePfFJLeO7ggho_iO0oLw4Mo-Yjc130_assertion description "[CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP634495.RAYurdp1yGzZXNnD3aePfFJLeO7ggho_iO0oLw4Mo-Yjc130_provenance.
- NP634490.RAC1-gJXV7lOX2dQhwBZBb3Ka-XZKN-rzfTjcMMZ36caM130_assertion description "[CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP634490.RAC1-gJXV7lOX2dQhwBZBb3Ka-XZKN-rzfTjcMMZ36caM130_provenance.
- NP55096.RA3ooSIo6lG7oPfsM9_kQvIqe_Z2yFv-dvafebzyT3hZ0130_assertion description "[CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP55096.RA3ooSIo6lG7oPfsM9_kQvIqe_Z2yFv-dvafebzyT3hZ0130_provenance.
- NP634491.RAmySoTlty69hsYPM046CHRWmZ3ZsI6c_Fxw1jWKPC6WI130_assertion description "[CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP634491.RAmySoTlty69hsYPM046CHRWmZ3ZsI6c_Fxw1jWKPC6WI130_provenance.
- NP256666.RA3qFYVV4QR4UNqiY1cwdmSS0VVxYX-Dsb-63bUEbKDVo130_assertion description "[CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP256666.RA3qFYVV4QR4UNqiY1cwdmSS0VVxYX-Dsb-63bUEbKDVo130_provenance.
- NP256215.RAFvapk0WHbe0_3GVAc20RSy5QR7UyGjw3KQD48fUly8g130_assertion description "[CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP256215.RAFvapk0WHbe0_3GVAc20RSy5QR7UyGjw3KQD48fUly8g130_provenance.
- NP256272.RAMVjUERyPRZQKNe7za-T6cuPOaZVSKvQJK81JONpW1oE130_assertion description "[CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP256272.RAMVjUERyPRZQKNe7za-T6cuPOaZVSKvQJK81JONpW1oE130_provenance.
- NP341549.RAFYIUHjsoLLwMxApA7gYvaCioNmY7xkh4het0h8biM2M130_assertion description "[CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP341549.RAFYIUHjsoLLwMxApA7gYvaCioNmY7xkh4het0h8biM2M130_provenance.
- NP114029.RAFKAEGbU5elTH-_1d1ymsI6WB4dY0IwoQ74QU30KQnC8130_assertion description "[CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP114029.RAFKAEGbU5elTH-_1d1ymsI6WB4dY0IwoQ74QU30KQnC8130_provenance.
- NP114030.RAJPuJp7HMDoQFs8IM0sd9B_RLZw0EU82g1rQyZ6VO0k4130_assertion description "[CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP114030.RAJPuJp7HMDoQFs8IM0sd9B_RLZw0EU82g1rQyZ6VO0k4130_provenance.
- NP634493.RAE0FwnUHMTCoVcqSQR1z-BdsutKrXIu04DtNPqKpu0WM130_assertion description "[CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP634493.RAE0FwnUHMTCoVcqSQR1z-BdsutKrXIu04DtNPqKpu0WM130_provenance.